Loading…
Treace Medical Concepts, Inc. is projected to rise to $4.91 by 2027, a +14% move from its current price of $4.31. TMCI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $4.15 | $4.31 | $4.49 | +0.09% |
| Aug 4 | $4.08 | $4.32 | $4.57 | +0.18% |
| Aug 5 | $4.04 | $4.32 | $4.63 | +0.27% |
| Aug 6 | $4.00 | $4.33 | $4.68 | +0.36% |
| Aug 7 | $3.96 | $4.33 | $4.73 | +0.45% |
| Aug 8 | $3.93 | $4.33 | $4.77 | +0.54% |
| Aug 9 | $3.91 | $4.34 | $4.82 | +0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.91 | $4.34 | $4.82 | +0.63% |
| Week 2 | $3.76 | $4.36 | $5.06 | +1.26% |
| Week 3 | $3.66 | $4.39 | $5.26 | +1.89% |
| Week 4 | $3.58 | $4.42 | $5.45 | +2.53% |
| Week 5 | $3.52 | $4.45 | $5.62 | +3.18% |
| Week 6 | $3.46 | $4.47 | $5.78 | +3.83% |
| Week 7 | $3.41 | $4.50 | $5.94 | +4.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States.
Its product portfolio includes the Lapiplasty System, which enables surgeons to correct all three dimensions of bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot. It also offers minimally invasive products for four bunion classes, the Nanoplasty 3D Minimally Invasive Bunion Correction System, the Percuplasty Percutaneous 3D Bunion Correction System, and the Adductoplasty System for correction of metatarsus adductus deformities and midfoot osteoarthritis; additional devices include SpeedMTP Rapid Compression Implant, SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot, SpeedPlate Micro-Quad implant, and SpeedAkin Anatomic Compression Implant. The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides and a pre-operative plan for a complete picture of the deformity and correction.
Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Treace Medical Concepts, Inc. (TMCI) is a healthcare company focused on medical devices for bunion correction and related foot procedures. The stock is currently priced at $4.38 with a market capitalization of $284.14M and a market position indicated by a rank of 3330.
The overall price outlook, based on the year-by-year forecast, shows a path of rising averages and substantial upside over time. The 2026 forecast lists an average of $4.38, with subsequent years projecting higher averages and bullish sentiment into the 2030s and 2040s, culminating in a 2050 average of $95.14 and a max of $207.89, representing notable long-term upside.
A major floor 72.2% below — a decisive break under it would weaken the trend.
The nearest floor, 7.9% below — buyers have tended to step in here.
The nearest ceiling, 8.1% above — a clean break opens room to run.
A major ceiling 16.1% above — clearing it would confirm fresh momentum.
Key TMCI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TMCI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.16 | Buy | $4.21 | Buy |
| MA 10 | $4.13 | Buy | $4.19 | Buy |
| MA 20 | $4.28 | Buy | $4.19 | Buy |
| MA 50 | $3.96 | Buy | $3.84 | Buy |
| MA 100 | $2.86 | Buy | $3.42 | Buy |
| MA 200 | $3.04 | Buy | $3.63 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.62 | Neutral |
| Stoch RSI (14) | 80.15 | Sell |
| CCI (20) | 10.40 | Neutral |
| Williams %R (14) | -27.66 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -2.05 | Sell |
| Bollinger %B (20,2) | 0.53 | Neutral |
| Stochastic %K (14) | 72.34 | Neutral |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 61.15 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 4.25 | Buy |
| ADX (14) | 14.25 | Neutral |
| ATR (14) | 0.15 | Info |
The near-term technical picture shows a bullish tilt with RSI(14) at 60. The 50-day simple moving average is $3.93, while the 200-day simple moving average is $3.05. The stock currently sits around a support level of $3.97 and faces a resistance level at $4.66.
Over the next 30 days, the price range spans from a low of $3.35 to a high of $5.73, indicating defined near-term volatility but a positive bias given the current bullish sentiment.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.20 | $4.31 | $6.05 | 0% | Neutral | |
| $3.75 | $4.91 | $6.87 | +14% | Neutral | |
| $4.77 | $6.51 | $9.60 | +51% | Bullish | |
| $5.89 | $8.33 | $12.76 | +93% | Bullish | |
| $7.49 | $10.94 | $17.32 | +154% | Bullish | |
| $9.20 | $13.84 | $22.55 | +221% | Bullish | |
| $9.10 | $14.07 | $23.51 | +226% | Bullish | |
| $9.92 | $15.75 | $26.92 | +265% | Bullish | |
| $10.95 | $17.83 | $31.11 | +314% | Bullish | |
| $10.91 | $18.21 | $32.39 | +323% | Bullish | |
| $18.13 | $33.88 | $65.25 | +686% | Bullish | |
| $42.55 | $94.56 | $203.92 | +20.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.20 | $4.31 | $5.33 | +0.00% |
| September 2026 | $3.68 | $4.41 | $5.47 | +2.24% |
| October 2026 | $3.86 | $4.68 | $5.89 | +6.11% |
| November 2026 | $3.96 | $4.83 | $6.17 | +3.38% |
| December 2026 | $3.82 | $4.69 | $6.05 | -2.92% |
Click any year to see its month-by-month TMCI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TMCI to range from $1.20 to $6.05 through 2026. The $4.31 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The TMCI price prediction for 2027 points to an average of $4.91 (low $3.75, high $6.87) — a potential gain of +14% on today's $4.31. A consolidation phase looks the most probable path here.
In 2028, TMCI is projected to trade between $4.77 and $9.60, averaging $6.51 — a potential gain of +51% from today's $4.31. That is up +33% on the projected 2027 average. Momentum favours further upside here.
Treace Medical Concepts, Inc.'s 2029 outlook centres on $8.33, within a $5.89 to $12.76 range. That is up +28% on the projected 2028 average. That marks a +93% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, TMCI could reach as high as $17.32, with a base case around $10.94 and support toward $7.49 — roughly +154% from $4.31. Momentum favours further upside here.
Expect TMCI to range from $9.20 to $22.55 through 2031. The $13.84 average target implies a +221% move from current prices. That is up +27% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The TMCI price prediction for 2032 points to an average of $14.07 (low $9.10, high $23.51) — a potential gain of +226% on today's $4.31. Momentum favours further upside here.
In 2033, TMCI is projected to trade between $9.92 and $26.92, averaging $15.75 — a potential gain of +265% from today's $4.31. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Treace Medical Concepts, Inc.'s 2034 outlook centres on $17.83, within a $10.95 to $31.11 range. That is up +13% on the projected 2033 average. That marks a +314% change versus current levels. Momentum favours further upside here.
By 2035, TMCI could reach as high as $32.39, with a base case around $18.21 and support toward $10.91 — roughly +323% from $4.31. Buyers look set to stay in control over this stretch.
Expect TMCI to range from $18.13 to $65.25 through 2040. The $33.88 average target implies a +686% move from current prices. That is up +86% on the projected 2035 average. Momentum favours further upside here.
The TMCI price prediction for 2050 points to an average of $94.56 (low $42.55, high $203.92) — a potential gain of +20.9x on today's $4.31. Buyers look set to stay in control over this stretch.
Investing $1,000 in TMCI today (≈ 232.018561 TMCI) could be worth
$21,940.42
+$20,940.42 (+2094%) by 2050 · US Dollar
Based on the average projected TMCI price of $94.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TMCIwould be worth at today's price.
$1,000 invested in TMCI on Jul 31, 2025 (≈ 186.219743 TMCI) would be worth
$802.61
-$197.39 (-19.7%) today · 0.80× · US Dollar
Based on a TMCI entry price of $5.37 vs. today's $4.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4 | $1,077.5 | +7.7% |
| 1 month ago | $4.23 | $1,018.91 | +1.9% |
| 3 months ago | $1.86 | $2,317.2 | +131.7% |
| 6 months ago | $2.26 | $1,907.08 | +90.7% |
| 1 year ago | $5.37 | $802.61 | -19.7% |
| All time (5.0y) ago | $29.26 | $147.3 | -85.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TMCI forecast.
Our base-case forecast reaches $8.60 around 2030.
Implied market cap at $8.60: $557.91M
The multi-year forecast depicts a fundamentally bullish trajectory with rising averages and sizable upside. In 2030 the average is projected to be $11.13, with a min of $7.56 and a max of $17.77, and an ROI of 154.2%.
By 2040, the average is projected to $34.05, the min $17.89, and the max $66.32, with an ROI of 677.4% and a bullish sentiment. By 2050, the average is projected to $95.14, with a min of $42.81 and a max of $207.89, delivering an ROI of 2072.2% and continuing a bullish stance.
These are estimates, not guarantees. The forecast implies meaningful upside from current levels if the projected path plays out, but actual results may differ due to market dynamics and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows min $7.56, avg $11.13, max $17.77, with an ROI of 154.2% and a BULLISH sentiment.
The forecast shows bullish sentiment in later years and rising averages, with 2040 and 2050 outlooks at $34.05 and $95.14 respectively and ROI of 677.4% and 2072.2%, though these are estimates, not guarantees.
Yes. The 2031 max is $23.07, and the 2030 max is $17.77, which indicates crossing $20 is within the forecast horizon; the 2040 max is $66.32 as an additional upper path.
Current price is $4.38 and market cap is $284.14M.
The 30-day range is $3.35 to $5.73; RSI(14) is 60; SMA50 is $3.93; SMA200 is $3.05. The near-term picture shows support at $3.97 and resistance at $4.66 with a bullish tilt.
Treace Medical Concepts, Inc. Community Discussion
0Share your Treace Medical Concepts, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.